Antimicrobial activity of de novo designed cationic peptides against multi-resistant clinical isolates.

[1]  G. Schneider,et al.  Designing antimicrobial peptides: form follows function , 2011, Nature Reviews Drug Discovery.

[2]  J. Wiesner,et al.  Antimicrobial peptides: The ancient arm of the human immune system , 2010, Virulence.

[3]  Ramesh Rathinakumar,et al.  Broad-spectrum antimicrobial peptides by rational combinatorial design and high-throughput screening: the importance of interfacial activity. , 2009, Journal of the American Chemical Society.

[4]  R. Gallo,et al.  AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. , 2009, Trends in immunology.

[5]  D. Douguet,et al.  HELIQUEST: a web server to screen sequences with specific alpha-helical properties , 2008, Bioinform..

[6]  Ronald N. Jones,et al.  Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections. , 2008, The Journal of antimicrobial chemotherapy.

[7]  A. Ulrich,et al.  Influence of C-terminal amidation on the antimicrobial and hemolytic activities of cationic α-helical peptides , 2007 .

[8]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[9]  H. Sahl,et al.  The co-evolution of host cationic antimicrobial peptides and microbial resistance , 2006, Nature Reviews Microbiology.

[10]  Ronald N. Jones,et al.  Omiganan Pentahydrochloride (MBI 226), a Topical 12-Amino-Acid Cationic Peptide: Spectrum of Antimicrobial Activity and Measurements of Bactericidal Activity , 2004, Antimicrobial Agents and Chemotherapy.

[11]  Ronald N. Jones,et al.  Quality Control Guidelines for MIC Susceptibility Testing of Omiganan Pentahydrochloride (MBI 226), a Novel Antimicrobial Peptide , 2004, Journal of Clinical Microbiology.

[12]  Alessandro Tossi,et al.  Amphipathic α helical antimicrobial peptides. , 2001 .

[13]  A. Tossi,et al.  Amphipathic alpha helical antimicrobial peptides. , 2001, European journal of biochemistry.

[14]  M. Yeaman,et al.  Immunocontinuum: perspectives in antimicrobial peptide mechanisms of action and resistance. , 2005, Protein and peptide letters.

[15]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .